Discover 776 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 776
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: New Braunfels TX, Fredericksburg TX, San Antonio TX,
Sponsor: BriaCell Therapeutics Corporation
Sex: All
Age: 18+
Code: NCT06072612
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
for
Hypothyroidism
Location: Round Rock TX, Austin TX, San Antonio TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06345339
Phase2, Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Austin TX, Bellaire TX, Richardson TX, Oklahoma City OK,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Austin TX, The Woodlands TX, Missouri City TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
for
Migraine
Location: Austin TX, Birmingham AL, Tampa FL, Mequon WI,
Sponsor: AbbVie
Sex: All
Age: 18 - 70
Code: NCT06602479
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: Austin TX, Metairie LA, Birmingham AL, Atlanta GA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
for
Acne Scars
Location: Pflugerville TX, Alpharetta GA, Glendale AZ, Vista CA,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT07207369
Phase3, Recruiting
Featured
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for
Non-Small Cell Lung Cancer,
Location: Austin TX, San Antonio TX, Houston TX, Irving TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05005403
Phase1, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Location: Austin TX, Oklahoma City OK, Nashville TN,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07024784
Phase2, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Cedar Park TX, Bellaire TX, Arlington TX, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase3, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for
Crohn's Disease
Location: Cedar Park TX, San Antonio TX, Mansfield TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT06548542
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Austin TX, Houston TX, Fort Worth TX, Grapevine TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07023289
Phase2, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Austin TX, Dallas TX, Tulsa OK, Kansas City MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
for
Solid Tumors Harboring MET Amplification
Location: Austin TX, San Antonio TX, Houston TX, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12+
Code: NCT07196644
Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Austin TX, Houston TX, Palestine TX, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
Featured
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
for
Psoriatic Arthritis
Location: Austin TX, San Antonio TX, Tomball TX, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06865105
Phase2, Recruiting
Active & Responsive
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder